I Novakova
Overview
Explore the profile of I Novakova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
643
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delory T, Seringe E, Antoniotti G, Novakova I, Goulenok C, Paysant I, et al.
Am J Infect Control
. 2015 Jul;
43(10):1070-5.
PMID: 26174583
Background: Carbapenemase-producing Enterobacteriaceae (CPE) are becoming of immediate concern for infection control policies. Prompt detection of CPE on health care setting admission is crucial to halt the spread of an...
2.
Lazarus C, Leclercq A, Lecuit M, Vaillant V, Coignard B, Blanchard H, et al.
J Hosp Infect
. 2013 Sep;
85(2):159-60.
PMID: 24001996
Listeria monocytogenes was isolated in two neonates born consecutively in the same hospital in France. The isolates had indistinguishable pulsed-field electrophoresis profiles. Retrospective epidemiological investigations found no evidence of a...
3.
Langford R, Mares J, Novotna A, Vachova M, Novakova I, Notcutt W, et al.
J Neurol
. 2012 Nov;
260(4):984-97.
PMID: 23180178
Central neuropathic pain (CNP) occurs in many multiple sclerosis (MS) patients. The provision of adequate pain relief to these patients can very difficult. Here we report the first phase III...
4.
Dardikh M, Albert T, Masereeuw R, Oldenburg J, Novakova I, van Heerde W, et al.
J Thromb Haemost
. 2012 Jan;
10(4):706-8.
PMID: 22284849
No abstract available.
5.
Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, et al.
Eur J Neurol
. 2011 Mar;
18(9):1122-31.
PMID: 21362108
Background: Spasticity is a disabling complication of multiple sclerosis, affecting many patients with the condition. We report the first Phase 3 placebo-controlled study of an oral antispasticity agent to use...
6.
Collin C, Ehler E, Waberzinek G, Alsindi Z, Davies P, Powell K, et al.
Neurol Res
. 2010 Mar;
32(5):451-9.
PMID: 20307378
Background: Muscle spasticity is common in multiple sclerosis (MS), occurring in more than 60% of patients. Objective: To compare Sativex with placebo in relieving symptoms of spasticity due to MS....
7.
Havrdova E, Zivadinov R, Krasensky J, Dwyer M, Novakova I, Dolezal O, et al.
Mult Scler
. 2009 May;
15(8):965-76.
PMID: 19465443
Background: Studies evaluating interferon beta (IFNbeta) for multiple sclerosis (MS) showed only partial efficacy. In many patients, IFNbeta does not halt relapses or disability progression. One strategy to potentially enhance...
8.
Verbruggen B, Meijer P, Novakova I, van Heerde W
Haemophilia
. 2008 Jun;
14 Suppl 3:76-82.
PMID: 18510526
The correct diagnosis of factor VIII deficiency and the assessment of severity of the disease are essential for a patient-tailored treatment strategy. An optimal diagnostic procedure comprises sensitive and specific...
9.
Kraft K, Verlaak R, van Heijst A, Novakova I, Brons P
Haemophilia
. 2008 Jan;
14(2):378-80.
PMID: 18179570
No abstract available.
10.
van der Heide H, Novakova I, de Waal Malefijt M
Haemophilia
. 2006 Nov;
12(6):679-82.
PMID: 17083522
The standard treatment for end-stage arthropathy of the ankle joint in haemophilia has been fusion of the ankle joint. Total ankle replacement is used in osteoarthritis and especially in rheumatoid...